![](https://assets-global.website-files.com/62ced6a68730ba27cb110c7b/62d71dcb4559455090cdc181_sogal-ventures-portflio-everly-health-1.jpg)
EverlyHealth
Revolutionizing the future of digital health
SoGal's 2nd investment. We believe the future of healthcare is consumerized, accessible, and autonomous
2017
$2M Revenue
$15M Valuation
2020
$1.3B
Unicorn
2022
$3.6B Valuation
$507M Actual Revenue
We believe the future of healthcare is consumerized, accessible, and autonomous and were delighted to discover Everlywell. We convinced Julia to take our $100K although her seed round was full.
We were able to help bring Series A investor back to the table when the deal almost didn't go through, negotiate valuations of financing rounds, and convince the current COO to join.
Julia later became a SoGal Fund I & II LP.
Everly Health became a unicorn in Q4 2020 and its valuation has grown 240X since we invested in 2017.
![](https://assets-global.website-files.com/62ced6a68730ba27cb110c7b/62d71ddac6043a7f114ef699_sogal-ventures-portflio-everly-health-founder-julia-cheek.jpg)
"I love SoGal."
Julia Cheek
![](https://assets-global.website-files.com/62ced6a68730ba27cb110c7b/62d71e7ce493872ffbdb3351_sogal-ventures-portflio-function-of-beauty-1.jpg)
next Case study